Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
REGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | GILD | REGN |
|---|
| Close | 150.89 | 789.45 |
| Market Cap | $183B | $79.7B |
| 1M | +5.19% | −2.57% |
| P/E (TTM) | — | 18.5 |
| Forward P/E | 25.3 | 14.1 |
| P/E 5-Yr Percentile | — | 48 |
| P/S | 6.0 | 5.2 |
| P/B | 15.3 | 2.5 |
| Dividend Yield | 3.98% | 0.47% |
| Latest Quarter Revenue | $7.8B | $4.3B |
| Revenue YoY | +10.2% | +16.7% |
| Gross Margin | 79.8% | — |
| Latest Quarter EPS | -8.45 | 12.23 |
| Avg Post-Earnings Move | ±3.8% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 4.61% |
| 90-Day Net Insider Buying | −$15.4M | −$3.4M |
GILD · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
